Anuh Pharma

₹82.79As of Sun 8 Nov 2026, 12:00 UTC

NSE:ANUHPHRHealthcare

Country India

PE (Fwd) 17.23

TSR 10Y CAGR —

Div yield 1.81%

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 0.48

PE TTM 20.22

TSR TTM (5.99%)

Mkt cap ₹8.416B

ROIC —

SE Grade™

Value

Quality

Moat

—

1Y Price

Reference

₹90

8.79%

(52.00%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

5Y

10Y

Peers

7.717

Revenue₹B

—

—

—

—

—

4.866

5.275

6.470

6.615

7.717

8.361

12.22%

12.22%

62

16.65

Revenue growth%

—

—

—

—

—

—

8.39

22.66

2.24

16.65

8.34

12.52

—

31

21.13

Gross margin%

—

—

—

—

—

21.72

22.74

24.05

23.40

21.13

21.16

22.74

22.74

3

7.32

Operating margin%

—

—

—

—

—

7.51

8.29

10.34

8.31

7.32

7.34

8.29

8.29

72

5.32

Net margin%

—

—

—

—

—

6.28

6.86

9.28

7.16

5.32

5.34

6.86

6.86

61

20.22

P/E ratio (avg)x

—

—

—

—

—

—

—

—

9.750

22.23

18.59

15.99

—

35

14.70

EV/EBITx

—

—

—

—

—

—

—

—

8.402

16.16

13.52

12.28

—

65

—

FCF yield (avg)%

—

—

—

—

—

—

—

—

—

—

—

—

—

59

—

FCF margin%

—

—

—

—

—

—

—

—

—

—

—

—

—

62

—

FCF / Net incomex

—

—

—

—

—

—

—

—

—

—

—

—

—

55

—

ROIC%

—

—

—

—

—

—

—

—

—

—

—

—

—

83

—

Return on equity%

—

—

—

—

—

—

—

—

—

—

—

—

—

83

—

Return on assets%

—

—

—

—

—

—

—

—

—

—

—

—

—

83

4.10

EPS₹

—

—

—

—

—

3.05

3.61

5.99

9.45

4.10

4.45

7.65%

7.65%

—

(56.66)

EPS growth%

—

—

—

—

—

—

18.38

66.00

57.69

(56.66)

8.71

38.04

—

50

—

Bookvalue per sh₹

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

FCF per share₹

—

—

—

—

—

—

—

—

—

—

—

—

—

—

1.50

Dividend per sh₹

—

—

—

—

—

0.88

1.00

1.25

1.50

1.50

1.57

14.42%

14.42%

—

1.81

Div yield (avg)%

—

—

—

—

—

—

—

—

1.63

1.65

1.90

1.64

—

27

36.63

Payout ratio%

—

—

—

—

—

28.70

27.70

20.86

15.87

36.63

35.28

27.70

27.70

50

100.2

Shares (diluted)M

—

—

—

—

—

100.2

100.2

100.2

50.11

100.2

◌100.2

—

—

68

(100.00)

Buyback yield%

—

—

—

—

—

—

—

—

50.00

(100.00)

◌—

—

—

68

—

D/E ratiox

—

—

—

—

—

—

—

—

—

—

—

—

—

72

8.298

Enterprise value₹B

—

—

—

—

—

—

—

—

4.617

9.126

8.298

97.65%

—

37

—

LT debt₹M

—

—

—

—

—

—

—

—

—

—

—

—

—

23

Peers (US$88.22M)

Cap (US$)

PE

Themis Medicare Limited

99.12M

23.97x

Amanta Healthcare…

80.74M

38.99x

ZIM Laboratories…

74.98M

326.5x

Ilyang Pharmaceutical…

88.15M

7.048x

Capital

TTM

5Y

10Y

Leveragex

—

—

—

EBIT/Intx

119.5

119.5

119.5

Own earn%

—

—

—

Sh yield%

(98.19)

—

—

Owners

Insiders/Inst%

72.67

—

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

5/5

Revenue growth years

4/4

EPS growth years

3/4

Dividend streakyrs

0

Op margin range%

7–10

$1 testx

—

Incr. ROIC%

—

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹7.717B

12.22%

1.00×

Cost of revenue

₹6.086B

12.43%

1.01×

Operating expenses

₹1.066B

11.42%

0.97×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

-

Return on capital

n/m

-

Spread over hurdle

n/m

-